Brief: Ocean Biomedical Extends Patent Rights For Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe
23/06/2023 13:04
June 23 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL (NASDAQ: OCEA) EXTENDS PATENT RIGHTS FOR
BREAKTHROUGH IDIOPATHIC PULMONARY FIBROSIS DISCOVERY TO EUROPE
Source text for Eikon: ID:nGNX32mXVc
Further company coverage: OCEA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26